Passage Bio Inc (PASG)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $13.68M
Last updated: Nov 17, 2026 at 11:06 AM ET
Passage Bio Inc (PASG) Earnings: Report Dates and Results
Passage Bio (PASG) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Passage Bio reported EPS of -$1.47, above the -$2.43 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
PASG has an expected report date of Mar 1, 2027.
Earnings History
Of the 28 quarters below that had an estimate, PASG beat 15, missed 10 and matched 3. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 46.07% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$1.47 | -$2.43 | N/A | +39.51% | Beat | N/A | 1 | 0 up, 0 down | Nov 10, 2026 | N/A |
| Jun 30, 2026 | -$2.44 | -$2.20 | -$3.47 - -$2.20 | -10.91% | Miss | N/A | 2 | 0 up, 1 down | Aug 10, 2026 | N/A |
| Mar 31, 2026 | -$2.36 | -$3.06 | -$3.24 - -$2.84 | +22.89% | Beat | N/A | 5 | 1 up, 0 down | May 12, 2026 | N/A |
| Dec 31, 2025 | -$4.09 | -$2.80 | -$2.98 - -$2.53 | -46.07% | Miss | N/A | 5 | 1 up, 0 down | Mar 3, 2026 | N/A |
| Sep 30, 2025 | -$2.44 | -$2.97 | -$3.13 - -$2.82 | +17.85% | Beat | N/A | 4 | 1 up, 0 down | Nov 10, 2025 | N/A |
| Jun 30, 2025 | -$2.96 | -$4.15 | -$5.00 - -$3.20 | +28.67% | Beat | N/A | 4 | 0 up, 3 down | Aug 12, 2025 | N/A |
| Mar 31, 2025 | -$5.00 | -$4.47 | -$4.60 - -$4.40 | -11.86% | Miss | N/A | 3 | 1 up, 0 down | May 13, 2025 | N/A |
| Dec 31, 2024 | -$0.20 | -$0.20 | -$0.24 - -$0.16 | 0.00% | In line | N/A | 2 | 1 up, 0 down | Mar 4, 2025 | N/A |
| Sep 30, 2024 | -$4.71 | -$4.67 | -$6.20 - -$2.60 | -0.86% | Miss | N/A | 5 | 0 up, 0 down | Nov 13, 2024 | $99000 |
| Jun 30, 2024 | -$5.20 | -$6.20 | -$6.60 - -$5.80 | +16.13% | Beat | N/A | 5 | 0 up, 0 down | Aug 8, 2024 | $2000 |
| Mar 31, 2024 | -$6.00 | -$6.90 | -$8.20 - -$6.40 | +13.04% | Beat | N/A | 4 | 0 up, 0 down | May 14, 2024 | N/A |
| Dec 31, 2023 | -$0.30 | -$0.40 | -$0.46 - -$0.35 | +25.00% | Beat | N/A | 5 | 0 up, 0 down | Mar 4, 2024 | $688000 |
| Sep 30, 2023 | -$7.93 | -$8.80 | -$10.40 - -$6.60 | +9.89% | Beat | N/A | 6 | 0 up, 0 down | Nov 13, 2023 | $148000 |
| Jun 30, 2023 | -$8.80 | -$9.55 | -$10.20 - -$9.00 | +7.85% | Beat | N/A | 7 | 0 up, 0 down | Aug 7, 2023 | $87000 |
| Mar 31, 2023 | -$12.60 | -$10.15 | -$11.40 - -$9.00 | -24.14% | Miss | N/A | 8 | 0 up, 0 down | May 11, 2023 | N/A |
| Dec 31, 2022 | -$0.49 | -$0.52 | -$0.73 - -$0.40 | +5.77% | Beat | N/A | 9 | 0 up, 0 down | Mar 6, 2023 | N/A |
| Sep 30, 2022 | -$9.80 | -$15.44 | -$21.80 - -$13.40 | +36.53% | Beat | N/A | 9 | 0 up, 0 down | Nov 10, 2022 | $110000 |
| Jun 30, 2022 | -$14.60 | -$15.93 | N/A | +8.35% | Beat | N/A | N/A | 0 up, 0 down | Aug 4, 2022 | N/A |
| Mar 31, 2022 | -$15.80 | -$18.38 | -$20.20 - -$15.40 | +14.04% | Beat | N/A | 9 | 0 up, 0 down | May 16, 2022 | N/A |
| Dec 31, 2021 | -$0.95 | -$0.89 | -$1.15 - -$0.74 | -6.74% | Miss | N/A | 9 | 0 up, 0 down | Mar 3, 2022 | N/A |
| Sep 30, 2021 | -$17.40 | -$17.40 | -$20.40 - -$14.20 | 0.00% | In line | N/A | 9 | N/A | Nov 4, 2021 | N/A |
| Jun 30, 2021 | -$18.00 | -$15.15 | -$16.80 - -$13.20 | -18.81% | Miss | N/A | 9 | N/A | Aug 5, 2021 | N/A |
| Mar 31, 2021 | -$15.20 | -$14.14 | -$18.20 - -$12.00 | -7.50% | Miss | N/A | 7 | N/A | May 5, 2021 | N/A |
| Dec 31, 2020 | -$0.85 | -$0.70 | -$0.86 - -$0.63 | -21.43% | Miss | N/A | 7 | N/A | Mar 3, 2021 | N/A |
| Sep 30, 2020 | -$12.60 | -$13.35 | -$19.60 - -$12.00 | +5.62% | Beat | N/A | 4 | N/A | Nov 10, 2020 | N/A |
| Jun 30, 2020 | -$12.00 | -$10.35 | -$13.00 - -$8.80 | -15.94% | Miss | N/A | 4 | N/A | Aug 13, 2020 | N/A |
| Mar 31, 2020 | -$7.76 | -$9.55 | -$9.60 - -$8.40 | +18.74% | Beat | N/A | 3 | N/A | May 11, 2020 | N/A |
| Dec 31, 2019 | -$0.69 | -$0.69 | N/A | 0.00% | In line | N/A | N/A | N/A | Feb 28, 2020 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$14.49, after -$16.11 the year before. It was -$0.69 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$14.49 | N/A |
| Dec 31, 2024 | -$16.11 | N/A |
| Dec 31, 2023 | -$29.63 | N/A |
| Dec 31, 2022 | -$40.69 | N/A |
| Dec 31, 2021 | -$51.55 | N/A |
| Dec 31, 2020 | -$33.21 | N/A |
| Dec 31, 2019 | -$0.69 | N/A |
Frequently Asked Questions About PASG
When is Passage Bio's next earnings date?
Passage Bio's next earnings report is expected for Mar 1, 2027.
Did PASG beat earnings estimates last quarter?
Yes. Passage Bio reported EPS of -$1.47 for the quarter ended Sep 30, 2026, above the -$2.43 estimate, a 39.51% surprise.
What EPS do analysts expect from PASG next quarter?
The consensus EPS estimate for Passage Bio for the quarter ending Dec 31, 2026 is -$2.60 from 5 analysts.
How often does PASG beat earnings estimates?
Passage Bio beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +5.01%.
PASG pages: Overview, Earnings, Forecast, Financials, Competitors